Biggest changeNON-GAAP RECONCILIATION OF EBITDA FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 2024 2023 Net (Loss) Income $ (2,479,661 ) $ 1,976,433 Stock-Based Compensation expense 450,000 - Depreciation & Amortization 2,765,713 2,769,284 Amortization of Debt Issuance Costs 9,222 12,451 Interest Expenses 738,010 642,314 Taxes (514,832 ) (719,172 ) Non-Recurring Items Anomalous Executive Transition expenses 379,389 - Nonrecurring professional Fees 174,500 - Technology Start-up Costs 344,496 - Optical Molding Evaluation Expenses 201,908 - Glass Molding Evaluation Expenses 130,196 - Sale of Equipment & Accessories - (10,068 ) Transaction Filing Fees - 344,752 Management Fees & Expenses - 318,334 Adjusted EBITDA $ 2,198,941 $ 5,334,328 In the years ended December 31, 2024 and 2023: ● A succession plan was required for the transition of the CEO at 2024 year-end. ● In both 2023 and 2024, Syntec recorded professional and transaction filing fees, as well as management fees and expenses related to its IPO filing with NASDAQ in November 2024.
Biggest changeNON-GAAP RECONCILIATION OF EBITDA FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 2025 2024 Net Loss $ (1,793,227 ) $ (2,479,661 ) Stock-Based Compensation Expense BOD (1) 300,000 450,000 Depreciation & Amortization 2,613,229 2,765,713 Amortization of Debt Issuance Costs 15,501 9,222 Interest Expenses 756,519 738,010 Taxes 439,942 (514,832 ) Non-Recurring Items Executive Transition (2) 579,161 379,389 Nonrecurring Banking Fees (3) 63,416 Nonrecurring professional Fees (4) 174,500 Technology Start-up Costs (5) 344,496 Optical Molding Evaluation Expenses (6) 201,908 Glass Molding Evaluation Expenses (6) 130,196 One-time Contract exit costs 21,063 Non-recurring property damage 21,261 Adjusted EBITDA $ 3,016,865 $ 2,198,941 In the years ended December 31, 2025 and 2024: (1) Stock-based compensation was issued to independent Board members.
Syntec Optics will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the consummation of OmniLit’s initial public offering, (ii) the last day of the fiscal year in which Syntec Optics has total annual gross revenue of at least $1.235 billion, (iii) the last day of the fiscal year in which Syntec Optics is deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of Syntec Optics’ common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year, or (iv) the date on which Syntec Optics has issued more than $1.0 billion in non- convertible debt securities during the prior three-year period. 37
Syntec Optics will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the consummation of OmniLit’s initial public offering, (ii) the last day of the fiscal year in which Syntec Optics has total annual gross revenue of at least $1.235 billion, (iii) the last day of the fiscal year in which Syntec Optics is deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of Syntec Optics’ common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year, or (iv) the date on which Syntec Optics has issued more than $1.0 billion in non- convertible debt securities during the prior three-year period. 36
We believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. 35 Inventory We periodically review physical inventory for excess, obsolete, and potentially impaired items and reserves. Any such inventory is written down to net realizable value.
We believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. Inventory We periodically review physical inventory for excess, obsolete, and potentially impaired items and reserves. Any such inventory is written down to net realizable value.
To mitigate against potential adverse production events, we opted to build our inventory of key raw materials. In connection with these stockpiling activities, we experienced an increase in prepaid inventory compared to prior periods as suppliers required upfront deposits in response to supply chain disruptions.
To mitigate against potential adverse production events, we opted to increase our inventory of key raw materials. In connection with these stockpiling activities, we experienced an increase in prepaid inventory compared to prior periods as suppliers required upfront deposits in response to supply chain disruptions.
Supply We currently rely on strategically selected electronics, highly engineered polymers and aluminum manufacturers located in the United States to manufacture our highly specialized optic and photonics enabled components and sub-components, and we intend to continue to rely on these suppliers going forward.
Supply We currently rely on strategically selected electronics, highly engineered polymers and aluminum manufacturers primarily located in the United States to manufacture our highly specialized optic and photonics enabled components and sub-components, and we intend to continue to rely on these suppliers going forward.
The price of our products may also increase as a result of increases in the cost of components due to inflation, labor and raw materials. Three customers accounted for 48% of revenues for the year ended December 31, 2024.
The price of our products may also increase as a result of increases in the cost of components due to inflation, labor and raw materials. Three customers accounted for 48% of revenues for the year ended December 31, 2025.
Total Other Income (Expense) Other income (expense) consists primarily of interest expense and debt issuance costs. 31 Results of Operations Comparisons for the Years Ended December 31, 2024 and 2023 The following table sets forth our results of operations for the years ended December 31, 2024 and 2023.
Total Other Income (Expense) Other income (expense) consists primarily of interest expense and debt issuance costs. 31 Results of Operations Comparisons for the Years Ended December 31, 2025 and 2024 The following table sets forth our results of operations for the years ended December 31, 2025 and 2024.
The table below presents our adjusted EBITDA, reconciled to net income for the years ended December 31, 2024 and 2023. 33 The table below presents our adjusted EBITDA, reconciled to net income for the periods indicated.
The table below presents our adjusted EBITDA, reconciled to net income for the years ended December 31, 2025 and 2024. 33 The table below presents our adjusted EBITDA, reconciled to net income for the periods indicated.
Syntec Optics focuses on four end markets of defense, medical, consumer, and communications all with several mission-critical applications with strong tailwinds. In 2023 and 2024, Syntec Optics launched low weight night vision optics and hybrid light-weight magnifiers and thermal clips in the defense end market. Syntec Optics also announced biomedical mirrors for sensing in the medical end market.
Syntec Optics focuses on four end markets of defense, medical, consumer, and communications all with several mission-critical applications with strong tailwinds. In the last three years Syntec Optics launched low weight night vision optics and hybrid light-weight magnifiers and thermal clips in the defense end market. Syntec Optics also announced biomedical mirrors for sensing in the medical end market.
This includes audit and regulation fees. ● Unique technology costs relate to digital imaging, as well as delivery of innovative solutions for distribution of new products to customers that we provided in the year ended December 31,2024. ● Optical and glass molding for special products produced on-demand production for key partners requiring components using ultra-precision glass pressing.
(5) Unique technology costs relate to digital imaging, as well as delivery of innovative solutions for distribution of new products to customers that we provided in the year ended December 31,2024. (6) Optical and glass molding for special products produced on-demand production for key partners requiring components using ultra-precision glass pressing.
This change was primarily due to a decrease in sales of $1.0 million, an increase in cost of goods sold of $1.2 million, an increase in general and administrative expenses of $1.9 million, an increase in other income (expense) of $0.1 million, and a decrease in provision for income taxes of $0.2 million.
This change was primarily due to a decrease in sales of $0.4 million, an decrease in cost of goods sold of $1.2 million, a decrease in general and administrative expenses of $1.2 million, an increase in other expenses of $0.4 million, and a decrease in benefit from provision for income taxes of $1.0 million.
We generate sales through (1) Tier 1 suppliers and (2) through OEMs. An increasing proportion of our sales has been and is expected to continue to be derived from sales to defense. biomedical and industrial/consumer OEMs, driven by continued efforts to develop and expand sales to OEMs with whom we have longstanding relationships.
An increasing proportion of our sales has been and is expected to continue to be derived from sales to defense. biomedical and industrial/consumer OEMs, driven by continued efforts to develop and expand sales to OEMs with whom we have longstanding relationships.
Our close working relationships with our Unites States based suppliers, reflected in our ability to (x) increase our purchase order volumes (qualifying us for related volume-based discounts) and (y) order and receive delivery of raw materials in anticipation of required demand, has helped us moderate increased supply-related costs associated with inflation and to avoid potential shipment delays.
Our close working relationships with our Unites States based suppliers, is reflected in our ability to) increase our purchase order volumes (qualifying us for related volume-based discounts), and ordering and receiving delivery of raw materials in anticipation of required demand, which has helped us moderate supply-related costs associated with inflation and to avoid potential shipment delays.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about a reporting entity’s effective tax rate reconciliation, as well as information related to income taxes paid to enhance the transparency and decision usefulness of income tax disclosures.
Recent Accounting Pronouncements In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires disaggregated information about a reporting entity’s effective tax rate reconciliation, as well as information related to income taxes paid to enhance the transparency and decision usefulness of income tax disclosures.
Investing Activities Net cash used in investing activities was $0.9 million for the year ended December 31, 2024, as compared to $1.9 million for the year ended December 31, 2023.
Investing Activities Net cash used in investing activities was $0.6 million for the year ended December 31, 2025, as compared to $0.9 million for the year ended December 31, 2024.
As of December 31, 2024, our reserve was approximately $0.5 million compared to $0.3 million as of December 31, 2023. 36 Income Taxes We account for income taxes using the asset and liability method.
As of December 31, 2025, our reserve was approximately $0.6 million compared to $0.5 million as of December 31, 2024. 35 Income Taxes We account for income taxes using the asset and liability method.
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 2024 2023 Net Cash (Used In) Provided By Operating Activities $ (942,830 ) $ 2,792,222 Net Cash Used in Investing Activities (930,866 ) (1,921,181 ) Net Cash Provided By Financing Activities 314,238 761,023 Net (Decrease) Increase in Cash (1,559,458 ) 1,632,064 Cash - Beginning 2,158,245 526,182 Cash - Ending $ 598,787 $ 2,158,245 Supplemental Cash Flow Disclosures: Cash Paid for Interest $ 738,010 $ 652,778 Cash Paid for Taxes $ 568,143 $ 283,561 Supplemental Disclosures of Non-Cash Investing Activities: Assets Acquired and Included in Accounts Payable and Accrued Expenses $ 198,584 $ 642,547 Issuance of finance lease for acquisition of equipment $ 2,160,070 $ - De-recognition of PPE and Intangible Asset transaction $ 560,000 $ - Operating Activities Net cash used in operating activities was ($0.9) million for the year ended December 31, 2024, as compared to net cash provided by operating activities of $2.8 million for the year ended December 31, 2023.
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 2025 2024 Net Cash Provided By (Used In) Operating Activities $ 672,635 $ (942,830 ) Net Cash Used in Investing Activities (644,292 ) (930,866 ) Net Cash (Used In) Provided By Financing Activities (268,263 ) 314,238 Net Decrease in Cash (239,920 ) (1,559,458 ) Cash - Beginning 598,787 2,158,245 Cash - Ending $ 358,867 $ 598,787 Supplemental Cash Flow Disclosures: Cash Paid for Interest $ 756,519 $ 738,010 Cash Paid for Taxes $ - $ 568,143 Supplemental Disclosures of Non-Cash Investing Activities: Assets Acquired and Included in Accounts Payable and Accrued Expenses $ 527,219 $ 198,584 Issuance of finance lease for acquisition of equipment $ - $ 2,160,070 De-recognition of PPE and Intangible Asset transaction $ - $ 560,000 Operating Activities Net cash provided by operating activities was $0.7 million for the year ended December 31, 2025, as compared to net used in operating activities of $0.9 million for the year ended December 31, 2024.
Net cash provided by financing activities was $0.8 million for the year ended December 31, 2023.
Financing Activities Net cash used in financing activities was $0.3 million for the year ended December 31, 2025. Net cash provided by financing activities was $0.3 million for the year ended December 31, 2024.
The primary drivers for the year-over-year change include a decrease in net income of $(4.5) million and additional funds provided of $0.8 million in balance sheet accounts including: accounts payable and accrued expense changes of $(2.3) million, changes in prepaid expenses of $(0.6) million, and changes in federal tax payable of $(0.5) million partially offset by changes in accounts receivable of $2.0 million, changes in inventory of $1.0 million, changes in deferred income taxes of $0.7 million and other operating asset and liability changes of $0.5 million including reduced grant revenue, reserves and allowances.
The primary drivers for the year-over-year change include an improvement in net loss of $0.7 million and additional funds provided of $0.9 million in balance sheet accounts including: accounts payable, accrued expense, and changes in prepaid expenses of $0.8 million, changes in federal tax payable of $0.6 million, changes in deferred income tax of $1.0 million, changes in inventory of $0.3 million, and changes from prior year gain on asset disposal of $0.3 million, partially offset by changes in accounts receivable of $(1.7) million, and other smaller changes of $(0.4) million.
In the event that actual results differ from these estimates, or we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial position and results of operations. Recent Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.
In the event that actual results differ from these estimates, or we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial position and results of operations.
The primary drivers for the year-over-year change include a decrease in borrowings of debt obligations of $0.6 million, an increase in repayment of finance lease obligations of $0.1 million, an increase in net repayments on Line of credit of $0.4 million, a decrease in funds from OLIT Trust of $1.9 million, and a decrease in repayments on debt obligations of $2.5 million.
The primary drivers for the year-over-year change include an increase in borrowings of debt obligations of $0.2 million, an increase in net borrowings on Line of credit of $0.8 million, offset by an increase in repayments on debt obligations of $1.3 million, an increase in repayment of finance lease obligations of $0.2 million.
Rounding out new product launches, in the communication end market, Syntec Optics launched microlens arrays and low earth satellite optics. The Business Combination On November 7, 2023, or the Closing Date, we consummated the Business Combination.
Rounding out new product launches, in the communication end market, Syntec Optics launched microlens arrays and low earth satellite optics.
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 2024 % of Net Sales 2023 % of Net Sales Net Sales $ 28,449,941 100 % $ 29,441,180 100 % Cost of Goods Sold 22,747,615 80 % 21,520,189 73 % Gross Profit 5,702,326 20 % 7,920,991 27 % General and Administrative Expenses 8,278,720 29 % 6,379,879 22 % (Loss) Income from Operations (2,576,394 ) -9 % 1,541,112 5 % Other Income (Expense) Other Income 346,835 1 % 370,914 1 % Interest Expense, Including Amortization of Debt Issuance Costs (764,934 ) -3 % (654,765 ) -2 % Total Other (Expense) (418,099 ) -1 % (283,851 ) -1 % (Loss) Income Before (Benefit From) Provision for Income Taxes (2,994,493 ) -11 % 1,257,261 4 % (Benefit From) Provision for Income Taxes (514,832 ) -2 % (719,172 ) -2 % Net (Loss) Income $ (2,479,661 ) -9 % $ 1,976,433 6 % Net Sales Net sales decreased by $1 million, or 3.4% to $28.4 million for the year ended December 31, 2024, as compared to $29.4 million for the year ended December 31, 2023.
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 2025 % of Net Sales 2024 % of Net Sales Net Sales $ 28,083,985 100 % $ 28,449,941 100 % Cost of Goods Sold 21,554,285 77 % 22,747,615 80 % Gross Profit 6,529,700 23 % 5,702,326 20 % General and Administrative Expenses 7,047,300 25 % 8,278,720 29 % Loss from Operations (517,600 ) -2 % (2,576,394 ) -9 % Other (Expense) Income Other (Expense) Income (39,875 ) 0 % 346,835 1 % Interest Expense, Including Amortization of Debt Issuance Costs (795,810 ) -3 % (764,934 ) -3 % Total Other Expense (835,685 ) -3 % (418,099 ) -1 % Loss Before Benefit From Provision for Income Taxes (1,353,285 ) -5 % (2,994,493 ) -11 % Provision for (Benefit From) Income Taxes 439,942 2 % (514,832 ) -2 % Net Loss $ (1,793,227 ) -6 % $ (2,479,661 ) -10 % Net Sales Net sales decreased by $0.4 million, or 1.3% to $28.1 million for the year ended December 31, 2025, as compared to $28.5 million for the year ended December 31, 2024.
This ASU will be effective for the annual period ending December 31, 2025 . ASU 2023-09 will be applied prospectively with the option for retrospective application for all prior periods presented. The Company is currently evaluating the impact of adopting this guidance on the Company’s current financial position, results of operations or financial statement disclosures.
ASU 2024-03 may be applied prospectively with the option for retrospective application for all prior periods presented. The Company is currently evaluating the impact of adopting this guidance on the Company’s current financial position, results of operations or financial statement disclosures. In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326).
Decreases in Consumer industry ($0.6 million), Defense industry ($1.0 million), and Medical industry ($0.4 million) were partially offset by a $1.0 million increase in the communications industry.
Increases in Consumer industry $1.1 million, Defense industry $0.3 million, and Medical industry $1.1 million were offset by a $2.9 million decrease in the communications industry.
Income Tax Expense (Benefit from) Income tax expense (benefit) decreased by $0.2 million, or 28%, to ($0.5) million for the year ended December 31, 2024, as compared to ($0.7) million for the year ended December 31, 2023, primarily due to reduced taxable income.
Income Tax Expense (Benefit from) Income tax benefit decreased by $1.0 million, to a provision of $0.4 million for the year ended December 31, 2025, as compared to a benefit of $0.5 million for the year ended December 31, 2024, primarily due to reduction of valuation.
Under this method of accounting, OmniLit was treated as the acquired company for financial statement reporting purposes. Key Factors Affecting Our Operating Results Our financial position and results of operations depend to a significant extent on the following factors: End Market Consumers The demand for our products ultimately depends on demand from customers in our current end markets.
Key Factors Affecting Our Operating Results Our financial position and results of operations depend to a significant extent on the following factors: End Market Consumers The demand for our products ultimately depends on demand from customers in our current end markets. We generate sales through (1) Tier 1 suppliers and (2) through OEMs.
This decrease was primarily due to an increase in cost of goods sold as a percentage of revenue. General and Administrative Expenses General and administrative expenses increased by $1.9 million, or 30%, to $8.3 million for the year ended December 31, 2024, as compared to $6.4 million for the year ended December 31, 2023.
Gross Profit Gross profit increased by $0.8 million, or 15%, to $6.5 million for the year ended December 31, 2025, as compared to $5.7 million for the year ended December 31, 2024. This increase was primarily due to a decrease in cost of goods sold, partially offset by a $0.4 million decrease in sales.
Cost of Goods Sold Cost of goods sold increased by $1.2 million, or 6%, to $22. 7 million for the year ended December 31, 2024, as compared to $21.5 million for the year ended December 31, 2023. This increase was primarily due to payroll costs (up $1.0 million) and material/ subcontractor expenses (up $0.2 million).
Cost of Goods Sold Cost of goods sold decreased by $1.2 million, or 5%, to $21.5 million for the year ended December 31, 2025, as compared to $22.7 million for the year ended December 31, 2024.
Net Income (Loss) Net income decreased by $4.5 million to ($2.5) million for the year ended December 31, 2024, as compared to $2.0 million for the year ended December 31, 2023.
Refer to Note 9, Income Taxes, for a detailed calculation and explanation for the reduction. Net Loss Net Loss decreased by $0.7 million to $1.8 million for the year ended December 31, 2025, as compared to $2.5 million for the year ended December 31, 2024.
The net cash used in investing activities decreased primarily due to an decrease in capital expenditures of $0.7 million and an increase in proceeds from sale of equipment of $0.3 million. Financing Activities Net cash provided by financing activities was $0.3 million for the year ended December 31, 2024.
The net cash used in investing activities decreased primarily due to a decrease in capital expenditures of $0.6 million in 2025 compared to 2024, and proceeds from sale of equipment of $0.3 million 2024, with no such sale of equipment talking place in 2025.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). ASU 2024-03 requires additional disclosure of specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses.
ASU 2024-03 requires additional disclosure of specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted.
This increase was primarily due to increases in salaries and wages (up $1.0 million), stock-based compensation to non-employee directors (up $0.5 million), insurance costs (up $0.3 million), research and development expenses (up $0.1 million), and building maintenance (up $0.1 million). 32 Total Other Income Other income (expense) decreased by $0.1 million, or 12% to ($0.4) million for the year ended December 31, 2024, as compared to other income of ($0.3) million for the year ended December 31, 2023.
This decrease was primarily due to decreases in wages and commissions ($0.6 million), decreases in R&D ($0.4 million), decrease in business insurance ($0.2 million), and other cumulative changes of ($0.1 million). 32 Total Other Expenses Other expenses increased by $0.4 million, to $0.8 million for the year ended December 31, 2025, as compared to other expense of $0.4 million for the year ended December 31, 2024.
ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. ASU 2024-03 may be applied prospectively with the option for retrospective application for all prior periods presented.
ASU 2025-11 is effective for public business entities for interim periods within fiscal years beginning after December 15, 2027, and for all other entities after December 15, 2028, with early adoption permitted. The amendments in this update are to be applied prospectively. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and disclosures.
The gain from sale of machinery and equipment was $0.3 million, offset by higher interest expense of $0.1 million and elevated rates for the debt facilities.
There was a gain from the sale of machinery and equipment in 2024 of $0.3 million, which did not exist in 2025.